Role of PET/CT in Peritoneal Deposits Assessment

Peritoneal Metastases Clinical Trial

Official title:

Role of PET/CT in Peritoneal Deposits Assessment

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06137417
• Other study ID #: PET CT peritoneal deposits
• Status: Not yet recruiting
• Start date: January 1, 2024
• Est. completion date: March 15, 2026

Study information

• Verified date: November 2023
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Description:

Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits. we will find its diagnostic role.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: March 15, 2026
• Est. primary completion date: January 1, 2026
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• • Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.

Exclusion Criteria:

• • Patients unable to sit calm without movement during imaging.

• Severely ill patients.

• Patients unable to sleep in a fixed position for 20 minutes.

• Pregnancy

Related Conditions & MeSH terms

• Neoplasm Metastasis
• Peritoneal Metastases

Intervention

Device:
• PET/CT
• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Aya Khaled Mahmoud

References & Publications (3)

Dawson H, Kirsch R, Messenger D, Driman D. A Review of Current Challenges in Colorectal Cancer Reporting. Arch Pathol Lab Med. 2019 Jul;143(7):869-882. doi: 10.5858/arpa.2017-0475-RA. Epub 2019 Jan 23. — View Citation

Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001 Jan;80(1):44-7. doi: 10.1006/gyno.2000.6036. — View Citation

Patel CM, Sahdev A, Reznek RH. CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging. 2011 Aug 24;11(1):123-39. doi: 10.1102/1470-7330.2011.0016. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	role of pet/ct in peritoneal deposits assessment	Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits	2 years